Discover Emergent BioSolutions' Q1 2025 progress: revenue growth, improved liquidity, NARCAN updates, and strategic outlook.

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

Visit a quote page and your recently viewed tickers will be displayed here.

Detailed price information for Emergent Biosolutions (EBS-N) from The Globe and Mail including charting and trades.